Comparison of the requirements for hepatic injury with halothane and enflurane in rats
- PMID: 4037395
Comparison of the requirements for hepatic injury with halothane and enflurane in rats
Abstract
A rat model of enflurane-associated hepatotoxicity was compared with the halothane-hypoxia (HH) model (adult male rats, phenobarbital induction, 1% halothane, 14% O2, for 2 hr). The enflurane-hypoxia heating (EHH) model involved exposing phenobarbital-pretreated male adult rats to 1.5-1.8% enflurane at 10% O2 for 2 hr with external heating to help maintain body temperature. Exposure to either anesthetic without temperature support led to a decrease in body temperature of 7-9 degrees C, while heating the animals during anesthesia resulted in only a 0.5-2 degree decrease. Reducing the oxygen tension to 10% O2 combined with heating the animals during exposure produced significant decreases in the oxidative metabolism of both halothane and enflurane as compared to exposures of 14% O2. The same conditions also caused a significant increase in the reductive metabolism of halothane, indicating that a severe hepatic hypoxia or anoxia occurs during anesthesia at 10% O2 with external heating. The time course of lesion development in the HH model paralleled results obtained with an oral dose of CCl4: gradual progression of necrosis up to 24 hr. EHH resulted in a classic hypoxic/anoxic injury with elevated serum glutamate pyruvate transaminase values and a watery vacuolization of centrilobular hepatocytes immediately after exposure. The HH model required phenobarbital pretreatment of the rats for expression of hepatic injury; EHH did not. Heating of the animals during anesthesia exposure was necessary for enflurane-induced hepatoxicity but had little effect on the HH model. Exposure to 5% O2 without anesthetic mimicked EHH in both requirements for and type of hepatic injury.
Similar articles
-
The effect of cimetidine on anesthetic metabolism and toxicity.Anesth Analg. 1986 May;65(5):481-8. Anesth Analg. 1986. PMID: 3963434
-
Toxicity and biotransformation of volatile halogenated anesthetics in rat hepatocyte suspensions.Drug Chem Toxicol. 1985;8(4):207-18. doi: 10.3109/01480548509038646. Drug Chem Toxicol. 1985. PMID: 4075996
-
Isoflurane and enflurane-induced hepatic necrosis in triiodothyronine-pretreated rats.Anesthesiology. 1983 Jan;58(1):1-5. doi: 10.1097/00000542-198301000-00001. Anesthesiology. 1983. PMID: 6848006
-
Absorption, biotransformation, and storage of halothane.Environ Health Perspect. 1977 Dec;21:165-9. doi: 10.1289/ehp.7721165. Environ Health Perspect. 1977. PMID: 348455 Free PMC article. Review.
-
[Effects of halogenated anesthetic agents on the liver].Cah Anesthesiol. 1989 Nov;37(7):531-7. Cah Anesthesiol. 1989. PMID: 2699272 Review. French. No abstract available.
Cited by
-
Halothane hepatotoxicity and hepatic free radical metabolism in guinea pigs; the effects of vitamin E.Can J Anaesth. 1996 Jul;43(7):741-8. doi: 10.1007/BF03017960. Can J Anaesth. 1996. PMID: 8807182
-
Influence of pentobarbital and chloralose on metabolic and hemodynamic changes in liver ischemia.Ann Surg. 1990 Jul;212(1):23-9. doi: 10.1097/00000658-199007000-00004. Ann Surg. 1990. PMID: 2363600 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical